...
机译:曲妥珠单抗在日本HER2阳性晚期胃或胃食管连接癌患者中的疗效:曲妥珠单抗用于胃癌(ToGA)研究的亚组分析
Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan;
Department of Biostatistics, Public Health Research Foundation, Tokyo, Japan;
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan;
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan;
Department of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan;
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
Department of Gastroenterology, Saku Central Hospital, Nagano, Japan;
Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan;
Division of Gastroenterology, Saitama Cancer Center, Saitama, Japan;
Department of Medical Oncology, Saitama International Medical Center–Comprehensive Cancer Center, Saitama Medical University, Saitama, Japan;
Department of Gastroenterology, National;
Trastuzumab; Drug therapy; Stomach neoplasms; Randomized controlled trial;
机译:曲妥珠单抗在日本HER2阳性晚期胃或胃食管连接癌患者中的疗效:曲妥珠单抗用于胃癌(ToGA)研究的亚组分析
机译:Pertuzumab Plus Trastuzumab和日本患者的化疗,Her2阳性转移性胃或胃食管癌症癌症:雅各布试验的亚组分析
机译:曲妥珠单抗在日本患者患有先前治疗的Her2阳性局部晚期或转移性胃或胃食管接线腺癌腺癌的疗效:盖茨比研究的亚组分析
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
机译:曲妥珠单抗在日本HER2阳性晚期胃或胃食管连接癌患者中的疗效:曲妥珠单抗用于胃癌(ToGA)研究的亚组分析
机译:曲妥珠单抗在日本HER2阳性晚期胃或胃食管连接癌患者中的疗效:曲妥珠单抗用于胃癌(ToGA)研究的亚组分析